Beijing Ruimait Medical Technology Co., Ltd. (hereinafter referred to as "the Company") held the 19th meeting of the 3rd Board of Directors on April 22, 2026, where it reviewed and approved the proposals regarding the profit distribution and capital reserve transfer plan for 2025, the change of registered capital and amendments to the Articles of Association, and the first vesting period of the 2025 restricted stock incentive plan. The proposals regarding the profit distribution and capital reserve transfer plan and the change of registered capital and amendments to the Articles of Association are subject to approval at the Company's 2025 annual shareholders' meeting. The relevant information is announced as follows:
301367SZSE
Announcement on Changes to Registered Capital and Amendments to the Articles of Association
✨ AI Summary
Beijing Ruimait Medical Technology Co., Ltd. plans to increase its registered capital from RMB 89.6 million to RMB 125.284355 million. This change involves a capital reserve transfer of 35,548,928 shares to shareholders. The amendments to the Articles of Association will also be submitted for approval at the 2025 annual shareholders' meeting.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.